Evidence map›Paper›PMID 36148292›Full record

ArticlePediatric gastroenterology, hepatology & nutrition2022

Mariko Meguro, Ryusuke Nambu, Tomoko Hara, Ryo Ebana, Masashi Yoshida, Saki Yamamoto, Koki Mori, Itaru Iwama

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric gastroenterology, hepatology & nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mariko MeguroDivision of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0001-9387-5073
Ryusuke NambuDivision of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-7206-7111
Tomoko HaraDivision of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-7306-836X
Ryo EbanaDivision of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-1276-736X
Masashi YoshidaDivision of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-9276-6665
Saki YamamotoDepartment of Laboratory Technology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-6546-1292
Koki MoriDepartment of Laboratory Technology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-4245-8584
Itaru IwamaDivision of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0001-8677-8195
Saitama Children's Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Toxins produced by Methods: We retrospectively analyzed the clinical data of children diagnosed with CDI between 2011 and 2021 at the Saitama Children's Medical Center in Saitama, Japan. Results: During the study period, 1,252 Conclusion: The number of pediatric patients with CDI is increasing. Both a comprehensive interview, including underlying diseases and history of antibiotic use, and an understanding of the features of clinical examinations should be emphasized to appropriately diagnose and treat CDI.

Indexed as

Antigens, CDCD toxinClostridioides difficileColonoscopyEnterocolitis, pseudomembranous

Identifiers

PMID36148292
PMCPMC9482825
OpenAlexW4295940840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.